Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Bain

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|November 7, 2019
An update to: Pharmacological treatment for type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK. Diabet Med 2019; 36: 1063-1071S C Bain, A Bakhai, M Evans, et al.
Diabetes|October 6, 1997
Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene). Association with urinary albumin excretion in IDDM patientsP M Hansen, T Chowdhury, T Deckert, et al.
QJM : Monthly Journal of the Association of Physicians|September 17, 2011
The management of diabetes in terminal illness related to cancerE J King, H Haboubi, D Evans, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 19, 1998
Factors associated with clinic non-attendance in adults with type 1 diabetes mellitusP H Dyer, C E Lloyd, R J Lancashire, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 17, 2012
Quality and Outcomes Framework screening questions for depression in patients with diabetes: effective but non-efficientS R Abu-Roomi, A Mallipedhi, S C Bain, et al.
Diabetologia|April 11, 2003
Nitric oxide synthase gene polymorphisms and diabetic nephropathyJ D Rippin, A Patel, N D Belyaev, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2011
Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetesR M Bracken, D J West, J W Stephens, et al.
Diabetologia|September 24, 1999
The 5'-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian type I diabetic patientsP H Dyer, T A Chowdhury, M J Dronsfield, et al.
Diabetes & Metabolism|October 2, 2012
Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetesJ Vora, S C Bain, T Damci, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 17, 2018
A retrospective observational study of people with Type 1 diabetes with self-reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist interventionB C T Field, R Nayar, A Kilvert, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Diabetic Medicine : a Journal of the British Diabetic Association|November 7, 2019
An update to: Pharmacological treatment for type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK. Diabet Med 2019; 36: 1063-1071S C Bain, A Bakhai, M Evans, et al.
Diabetes|October 6, 1997
Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene). Association with urinary albumin excretion in IDDM patientsP M Hansen, T Chowdhury, T Deckert, et al.
QJM : Monthly Journal of the Association of Physicians|September 17, 2011
The management of diabetes in terminal illness related to cancerE J King, H Haboubi, D Evans, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 19, 1998
Factors associated with clinic non-attendance in adults with type 1 diabetes mellitusP H Dyer, C E Lloyd, R J Lancashire, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 17, 2012
Quality and Outcomes Framework screening questions for depression in patients with diabetes: effective but non-efficientS R Abu-Roomi, A Mallipedhi, S C Bain, et al.
Diabetologia|April 11, 2003
Nitric oxide synthase gene polymorphisms and diabetic nephropathyJ D Rippin, A Patel, N D Belyaev, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2011
Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetesR M Bracken, D J West, J W Stephens, et al.
Diabetologia|September 24, 1999
The 5'-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian type I diabetic patientsP H Dyer, T A Chowdhury, M J Dronsfield, et al.
Diabetes & Metabolism|October 2, 2012
Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetesJ Vora, S C Bain, T Damci, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 17, 2018
A retrospective observational study of people with Type 1 diabetes with self-reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist interventionB C T Field, R Nayar, A Kilvert, et al.
Pageof 11